{"@attributes":{"version":"2.0"},"channel":{"title":"Blog","link":"https:\/\/blog.mediately.co","description":"Discover the latest trends in the pharmaceutical industry, gain insights into doctors' behavior, and explore effective digital advertising solutions.","language":"en","pubDate":"Wed, 17 Dec 2025 09:46:22 GMT","item":[{"title":"Advancing early breast cancer treatment through precision oncology","link":"https:\/\/blog.mediately.co\/dejan-juric-interview","description":"
\n \"Advancing <\/a> \n<\/div> \n

We had the opportunity to speak with Assist. Prof. Dejan Juric, a Croatian-American clinical investigator, Harvard professor of oncology, and medical oncology specialist at Massachusetts General Hospital<\/span>, to discuss current developments and future directions in early breast cancer care.<\/span> <\/p>","category":"Interview","pubDate":"Mon, 03 Nov 2025 13:40:14 GMT","guid":"https:\/\/blog.mediately.co\/dejan-juric-interview"},{"title":"The future of diabetes: Prevention, personalization, and progress","link":"https:\/\/blog.mediately.co\/the-future-of-diabetes-prevention-personalization-and-progress","description":"

\n \"cover-image\" <\/a> \n<\/div> \n

Professor Stefano del Prato<\/span>, a globally recognized diabetologist and researcher, recently shared his invaluable insights on the evolving landscape of type 2 diabetes care. With decades of experience in diabetes research and clinical practice, professor Stefano del Prato highlighted the transformative advancements in treatment, the critical role of prevention, and the promising future of personalized medicine. His reflections underscore the importance of innovation<\/span>, collaboration<\/span>, and patient-centered approaches<\/span> in addressing the challenges of diabetes care.<\/span><\/p>","category":"Interview","pubDate":"Wed, 19 Feb 2025 08:06:53 GMT","guid":"https:\/\/blog.mediately.co\/the-future-of-diabetes-prevention-personalization-and-progress"},{"title":"How digitalization is shaping healthcare: Insights from a leading Czech oncologist","link":"https:\/\/blog.mediately.co\/how-digitalization-is-shaping-healthcare-insights-from-a-leading-czech-oncologist","description":"

\n \"cover-image\" <\/a> \n<\/div> \n

Dr. Petr\u00e1kov\u00e1 is a distinguished authority in Czech oncology. She has been working at the Masaryk Memorial Cancer Institute (MO\u00da) in Brno since 1993, where she is also a Head Physician at the Clinic of Comprehensive Cancer Care. She is the founder of St. Elizabeth Hospice, an accomplished author and reviewer of scientific articles and publications, as well as a passionate lecturer and mentor. She also has a long-standing commitment to the specialised team, focusing on breast cancer treatment.

As a member of the Czech Society for Oncology (\u010cLS JEP) and the European Society for Medical Oncology, Dr. Petr\u00e1kov\u00e1 contributes significantly to the advancement of oncology on both national and European levels.<\/p> \n

 <\/p>","category":"Interview","pubDate":"Thu, 13 Feb 2025 07:20:19 GMT","guid":"https:\/\/blog.mediately.co\/how-digitalization-is-shaping-healthcare-insights-from-a-leading-czech-oncologist"},{"title":"5 ways to market to doctors: catching their attention in a busy world","link":"https:\/\/blog.mediately.co\/5-ways-to-market-to-doctors","description":"

\n \"5-ways-to-market-to-doctors-cover\" <\/a> \n<\/div> \n

Imagine this: you are at a busy medical conference, surrounded by doctors fresh from a morning packed with back-to-back surgeries and patient consultations. Their phones are buzzing, medical journals are stacked high, and their schedules are crammed for months. These professionals make life-or-death decisions every day, and now, here you are, a marketer, trying to get their attention for your product or service. How can you ensure they stop, listen, and actually consider what you have to offer?<\/span>

Marketing to doctors can feel like an uphill battle. They are one of the most informed, yet time-pressed audiences out there. So how do you, as a marketer, break through the noise and connect with them in a way that\u2019s meaningful and impactful?

The answer lies in how you approach them<\/span>. Forget about broad, generic marketing blasts. In a world where personalization is key and attention spans are short, it\u2019s all about strategically targeting their specific needs and offering concrete value. So let\u2019s dive quickly into five ways to market to doctors that will help you cut through the clutter and ensure your message resonates.<\/p>","category":"Healthcare marketing","pubDate":"Wed, 30 Oct 2024 14:06:33 GMT","guid":"https:\/\/blog.mediately.co\/5-ways-to-market-to-doctors"},{"title":"Understanding doctors\u2019 behaviour: How cardiologists use our app for disease management","link":"https:\/\/blog.mediately.co\/cardiology-disease-management","description":"

\n \"disease-management\" <\/a> \n<\/div> \n

In cardiology, staying updated on the latest drug information and treatment protocols is essential. Our app, designed specifically for healthcare professionals, has become an indispensable tool for cardiologists, assisting them in disease management. In this post, we will explore cardiologist behavior in our app, focusing on how doctors in Romania search for drugs and improve patient outcomes.   <\/p> \n

 <\/p> \n

<\/em><\/p>","category":"Healthcare trends","pubDate":"Wed, 25 Sep 2024 07:03:20 GMT","guid":"https:\/\/blog.mediately.co\/cardiology-disease-management"},{"title":"Polypharmacy and quality of life","link":"https:\/\/blog.mediately.co\/polypharmacy-and-quality-of-life","description":"

\n \"polypharmacy-and-quality-of-life\" <\/a> \n<\/div> \n

Due to chronic diseases and polypharmacy, the medication-related burden for patients is steadily increasing and consequently leading to worse clinical results and an overall decrease in the quality of patients\u2019 lives. This multidimensional burden includes concerns regarding the use of medicines, financial difficulties, unwanted side effects and other problems that harm the patient\u2019s everyday life. Alleviating the medication-related burden is one of the key focal points on the way to improve the patient\u2019s health and quality of life.<\/em><\/p>","category":"Healthcare trends","pubDate":"Mon, 01 Jul 2024 08:38:39 GMT","guid":"https:\/\/blog.mediately.co\/polypharmacy-and-quality-of-life"},{"title":"We have to pursue the best glucose control possible","link":"https:\/\/blog.mediately.co\/francesco-giorgino-interview","description":"

\n \"FG-interview\" <\/a> \n<\/div> \n

It has been a while since Prof. Dr. Francesco Giorgino, currently vice-president of EASD and professor of endocrinology and metabolism, Head of the Division of Endocrinology at the University Hospital Policlinico Consorziale, University of Bari Aldo Moro in Italy talked with us about new trends in the management of diabetes. His words are still more than worth remembering. <\/p>","category":"Interview","pubDate":"Mon, 27 May 2024 08:48:03 GMT","guid":"https:\/\/blog.mediately.co\/francesco-giorgino-interview"},{"title":"Dermatology drug search trends, with a focus on atopic dermatitis & plaque psoriasis treatments","link":"https:\/\/blog.mediately.co\/dermatology-drug-search-trends","description":"

\n \"dermatology-drug-search\" <\/a> \n<\/div> \n

In dermatology, few conditions carry as much significance and impact as atopic dermatitis and plaque psoriasis. These two chronic skin disorders share the commonality of affecting millions of individuals worldwide, profoundly influencing their quality of life and necessitating ongoing management and treatment.

Overall, the treatment landscape for atopic dermatitis and plaque psoriasis is evolving quickly, with advancements in biologic therapies, Janus kinase (JAK) inhibitors, personalized medicine, and topical treatments. Pharmaceutical companies face increasing competition as they strive to develop innovative therapies that address the unmet needs of patients with these chronic skin disorders.<\/p>","category":["Research","Healthcare trends"],"pubDate":"Wed, 08 May 2024 08:59:59 GMT","guid":"https:\/\/blog.mediately.co\/dermatology-drug-search-trends"},{"title":"Polypharmacy: perhaps it hurts, but it will never go away","link":"https:\/\/blog.mediately.co\/polypharmacy","description":"

\n \"polypharmacy\" <\/a> \n<\/div> \n

Almost half of 9300 Mediately app users<\/span> (47% precisely) who participated in this year\u2019s Digital Doctor Survey, said their average patient is taking at least  5 drugs. Surprised? I believe not. Polypharmacy is a widespread and overwhelming phenomenon. However, answers to Digital Doctor<\/a> questions about polypharmacy revealed many new aspects. A bit of a surprising fact: on the topic of polypharmacy being either an offensive or defensive type of medical practice, Mediately doctors in our survey were almost tied, with 48% declaring it an offensive and 52% a defensive type of medical practice. They are practically divided in half!<\/p>","category":["Survey","Healthcare trends","Pharma trends"],"pubDate":"Tue, 09 Apr 2024 09:18:52 GMT","guid":"https:\/\/blog.mediately.co\/polypharmacy"},{"title":"Obesity drug search trends","link":"https:\/\/blog.mediately.co\/obesity-drug-search-trends","description":"

\n \"obesity-drug-trends\" <\/a> \n<\/div> \n

According to the World Health Organization (WHO), Europe is experiencing a steady increase in obesity rates. Overweight and obesity affect almost 60% of adults and nearly one in three children (\u200e29% of boys and 27% of girls)\u200e in the WHO European Region. Living with overweight or obesity has been identified as a serious public health challenge as it is a major determinant of death and disability.1  <\/sup><\/p>","category":["Research","Healthcare trends"],"pubDate":"Wed, 27 Mar 2024 12:30:30 GMT","guid":"https:\/\/blog.mediately.co\/obesity-drug-search-trends"}]}}